Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
34
|
pubmed:dateCreated |
1994-9-22
|
pubmed:abstractText |
Receptors for a variety of hematopoietins, interferons alpha/beta and gamma, and growth hormone have recently been shown to mediate rapid, ligand-dependent activation of the Janus-type cytosolic protein-tyrosine kinases Jak1, Jak2, and/or tyk-2. This finding extends relatedness among class I and II cytokine receptors to a functional context and provides an initially satisfying mechanistic analogy to protein-tyrosine kinase-encoding receptors of the epidermal growth factor/platelet-derived growth factor/insulin family. Through the construction and expression of a kinase-deficient form of Jak2 (JK2 delta VIII) in interleukin-3 (IL-3)/erythropoietin (Epo)-dependent DAER cells, we have tested whether activation of Jak2 is required for induced mitogenesis via these class I cytokine receptors. Ectopic expression of JK2 delta VIII inhibited Epo- and IL-3-induced activation of endogenous wild-type Jak2, transiently attenuated IL-3-dependent growth, and essentially abrogated Epo-induced proliferation in this model system. These dominant-negative effects provide the first direct experimental evidence for an essential role for Janus kinase activation in mitogenesis and suggest that distinct effectors may mediate IL-3-induced versus Epo-induced pathways.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Erythropoietin,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-3,
http://linkedlifedata.com/resource/pubmed/chemical/Janus Kinase 2,
http://linkedlifedata.com/resource/pubmed/chemical/Mitogens,
http://linkedlifedata.com/resource/pubmed/chemical/Protein-Tyrosine Kinases,
http://linkedlifedata.com/resource/pubmed/chemical/Proto-Oncogene Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Interleukin-3
|
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0021-9258
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
26
|
pubmed:volume |
269
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
21411-4
|
pubmed:dateRevised |
2009-11-19
|
pubmed:meshHeading |
pubmed-meshheading:8063772-Amino Acid Sequence,
pubmed-meshheading:8063772-Animals,
pubmed-meshheading:8063772-Base Sequence,
pubmed-meshheading:8063772-Cell Division,
pubmed-meshheading:8063772-Cells, Cultured,
pubmed-meshheading:8063772-DNA Mutational Analysis,
pubmed-meshheading:8063772-Erythropoietin,
pubmed-meshheading:8063772-Interleukin-3,
pubmed-meshheading:8063772-Janus Kinase 2,
pubmed-meshheading:8063772-Mitogens,
pubmed-meshheading:8063772-Molecular Sequence Data,
pubmed-meshheading:8063772-Phosphorylation,
pubmed-meshheading:8063772-Protein-Tyrosine Kinases,
pubmed-meshheading:8063772-Proto-Oncogene Proteins,
pubmed-meshheading:8063772-Receptors, Interleukin-3,
pubmed-meshheading:8063772-Signal Transduction
|
pubmed:year |
1994
|
pubmed:articleTitle |
Inhibition of erythropoietin-induced mitogenesis by a kinase-deficient form of Jak2.
|
pubmed:affiliation |
Department of Biochemistry, Pennsylvania State University, University Park 16802.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|